Skip Navigation



ToxSci Advance Access published online on June 9, 2005
Toxicological Sciences, doi:10.1093/toxsci/kfi217
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
87/1/86    most recent
kfi217v2
kfi217v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Morris, J. B.
Right arrow Articles by Pottenger, L. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morris, J. B.
Right arrow Articles by Pottenger, L. H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org
Received March 3, 2005
Accepted May 27, 2005

Immunotoxiocology

Uptake of Inspired Propylene Oxide in the Upper Respiratory Tract of the F344 Rat

John B. Morris 1*, Marcy I. Banton 2, and Lynn H. Pottenger 3

1 Department of Pharmaceutical Sciences, School of Pharmacy, 372 Fairfield Rd., Box U-2092, University of Connecticut, Storrs, CT 06269-2092
2 Lyondell Chemical Company, Houston, TX 77010
3 Toxicology and Environmental Research and Consulting, The Dow Chemical Company, Midland, MI 48674

* To whom correspondence should be addressed.
John B. Morris, E-mail: morris{at}uconnvm.uconn.edu


  Abstract

Propylene oxide (1,2-epoxypropane) is a nasal toxicant and weak site-of-contact carcinogen in the rodent. The current study was aimed at providing quantitative information on upper respiratory tract (URT) dosimetry of this vapor. Since depletion of nasal non-protein sulfhdryls (NPSH) may be important in the toxicity of this vapor and may serve as a biomarker for delivery of propylene oxide to nasal tissues, measurements of respiratory and olfactory NPSH content after propylene oxide exposure were also made. Towards these ends, uptake of this vapor was measured in the surgically isolated URT of the F344 rat at constant velocity inspiratory flow rates of 50 or 200 ml/min throughout a 60 minute exposure. Immediately after exposure, nasal respiratory and olfactory tissues were removed and analyzed for NPSH content. Propylene oxide was scrubbed from the airstream with moderate efficiency in the isolated URT. Similar uptake efficiencies were observed at inspired concentrations of 25, 50, 100, and 300 ppm, averaging 25% and 11% at flow rates of 50 and 200 ml/min, respectively. After 1 hour exposure to concentrations of 100 ppm or more, statistically significant depletion of nasal respiratory mucosal NPSH was observed. Nasal respiratory mucosal NPSH levels averaged approximately 90, 70, 50, 40, and 15% of control levels after 1 hour exposure to 25, 50, 100, 300, or 500 ppm propylene oxide. Olfactory mucosal NPSH levels also generally decreased at 300 or 500 ppm propylene oxide, but did not demonstrate statistically significant, consistent changes after propylene oxide exposure.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Immunol.Home page
F.-D. Shi, W.-H. Piao, Y.-P. Kuo, D. I. Campagnolo, T. L. Vollmer, and R. J. Lukas
Nicotinic Attenuation of Central Nervous System Inflammation and Autoimmunity
J. Immunol., February 1, 2009; 182(3): 1730 - 1739.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
D S Majka and V M Holers
Cigarette smoking and the risk of systemic lupus erythematosus and rheumatoid arthritis.
Ann Rheum Dis, May 1, 2006; 65(5): 561 - 563.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.